Following recent news on the amendments to the Patented Medicines Regulations and related guidance, the Patented Medicine Prices Review Board has announced that:

  • the amended Patented Medicines Regulations will now come into force on 1 January 2021; and
  • a revised set of draft guidelines will be published during the week of 15 June 2020, followed by a 30-day consultation period.

The most immediate and practical effect of this change is that reporting requirements due by 30 July 2020 of sales and pricing information for the period from 1 January 2020 to 30 June 2020 will be governed by the current regulations.

For further information on this topic please contact Abigail Smith or Nancy Pei at Smart & Biggar's Toronto office by telephone (+1 416 593 5514) or email ([email protected] or [email protected]). Alternatively, please contact Daphne Lainson at Smart & Biggar's Ottawa office by telephone (+1 613 232 2486) or email ([email protected]). The Smart & Biggar website can be accessed at www.smart-biggar.ca.